Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06420219 · ClinicalTrials.gov registry record
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
A clinical trial of Head and Neck Carcinoma, sponsored by University of Southern California.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06420219: Recruiting study of Head and Neck Carcinoma, sponsored by University of Southern California.
NCT06420219 is a study of Head and Neck Carcinoma that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 50 participants, below the 412-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06420219, a study of Head and Neck Carcinoma, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2029-03-25 |
What NCT06420219 shows while recruiting
NCT06420219 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 412-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06420219 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06420219 about?
NCT06420219 is a clinical study titled "An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence". This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.
What is the current status of trial NCT06420219?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-03-25. Estimated completion is 2029-03-25.
What conditions does trial NCT06420219 study?
This clinical trial studies the following conditions: Head and Neck Carcinoma.
What interventions are being tested in trial NCT06420219?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06420219?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06420219 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06420219's enrollment target sits among peer trials
50 14th of 30 higher than 15 of 30 other Head and Neck Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Head and Neck Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
RECRUITING · Phase 1
-
A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial
RECRUITING · NA
-
Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer
RECRUITING · NA
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI